LONDON A new cancer drug called Tykerb from GlaxoSmithKline may help stop breast cancer from recurring because of its ability to decrease tumor-causing breast cancer stem cells, according to published reports.
LONDON As a result of a struggling market, GlaxoSmithKline has turned its attention toward reinventing old drugs to treat different ailments, rather than making new drugs, according to published reports.
WASHINGTON Researchers from the Dana Farber Cancer Institute in Boston have revealed that the cancer drug Gleevec, used to treat metastatic melanoma, was able to force the cancer into remission for the first time.
CHICAGO A pooled analysis presented at the annual Academy of Neurology meeting reports that Pfizer’s Lyrica reduced pain in patients with fibromyalgia, whether or not they experienced symptoms of anxiety or depression.
Which area of the industry do you think Amazon’s entry would shake up the most?